Antibodies have been successfully used to treat human cancers by blocking the PD-1 signaling to enhance T cell activity and augment the lytic function of NK cells, illustrating the great value of PD-1 as a target for cancer therapy55. The gene discussed is PDCD1; the disease is cancer.